T-Cell study funded

Article

The National Institutes of Health (NIH) National Cancer Institute has granted $124,000 to Aastrom Biosciences, Inc. to develop an immunotherapeutic treatment of malignant melanoma using AastromReplicell System cell production technology.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.